back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-21 13:55 Tx date 2025-10-14 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$1,309,836 vol |
$1,309,836 | |
| Filed 2025-10-21 13:54 Tx date 2025-10-21 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Holder: Phantom Technologies Corp. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,078,000 vol |
22,000 | |
| Filed 2025-10-21 13:53 Tx date 2025-10-21 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-368,460 vol |
7,519 | |
| Filed 2025-10-17 18:10 Tx date 2025-10-14 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1 vol $1,309,836 each |
||
| Filed 2025-10-17 18:10 Tx date 2025-10-14 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
|
$
+$1 vol $1,309,836 each |
$1 | |
| Filed 2025-10-17 18:00 Tx date 2018-06-22 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 15:52 Tx date 2025-09-24 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-62,000 vol |
0 | |
| Filed 2024-01-11 14:50 Tx date 2024-01-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Holder: Phantom Technologies Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+100,000 vol $0.035 each |
1,100,000 | |
| Filed 2024-01-11 14:50 Tx date 2024-01-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Holder: Phantom Technologies Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+500,000 vol $0.03 each |
1,000,000 | |
| Filed 2022-12-14 21:21 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Bartch, David Joshua
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Mydecine Innovations Group Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-12-14 21:17 Tx date 2022-12-09 |
$NARA
Pangenomic Health Inc. |
Bartch, David Joshua
8 - Deemed Insider - 6 Months before becoming Insider
Holder: Mydecine Innovations Group Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,000,000 | ||
| Filed 2022-09-14 14:40 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,038,000 vol |
62,000 | |
| Filed 2022-09-14 14:34 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-18,422,961 vol |
375,979 | |
| Filed 2022-09-14 14:30 Tx date 2021-03-08 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+4,000,000 vol |
24,400,000 | |
| Filed 2022-05-24 17:45 Tx date 2022-01-11 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+500,000 vol |
14,798,940 | |
| Filed 2022-05-24 17:44 Tx date 2021-11-24 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+5,298,940 vol |
14,298,940 | |
| Filed 2022-05-24 17:43 Tx date 2021-07-30 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-200,000 vol |
9,000,000 | |
| Filed 2022-05-24 17:42 Tx date 2021-06-30 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
9,200,000 | |
| Filed 2022-05-24 17:41 Tx date 2021-05-31 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-300,000 vol |
9,500,000 | |
| Filed 2022-05-24 17:40 Tx date 2021-05-04 |
$MYCO
Mydecine Innovations Group Inc. |
Bartch, David Joshua
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-10,000,000 vol |
9,800,000 |